Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:VEON
NasdaqGS:VEONWireless Telecom

Assessing VEON (NasdaqGS:VEON) Valuation As AI And JazzCash Milestones Signal Ongoing Digital Shift

VEON (VEON) is back in focus after its JazzCash unit in Pakistan reached 1 million Raast QR enabled merchants, highlighting how the group’s digital payments and AI heavy strategy could matter for shareholders. See our latest analysis for VEON. Recent announcements on JazzCash, sovereign AI, and Kyivstar’s Nasdaq listing have arrived during a softer patch for the shares, with a 30 day share price return of 10.27% decline and a year to date share price return of 9.45% decline, even as the 1...
NasdaqGS:PGNY
NasdaqGS:PGNYHealthcare

A Look At Progyny (PGNY) Valuation After A Steep Three Month Share Price Pullback

Progyny stock performance sets the stage for closer review Progyny (PGNY) has been under pressure, with the share price showing a 1.5% decline over the past day, a 5.8% decline over the past month, and a 35.5% decline over the past 3 months. These moves, alongside recent financial figures such as US$1.29b in revenue and US$58.52m in net income, are prompting some investors to reassess what they are paying for the company’s fertility and family benefits business. See our latest analysis for...
NasdaqGS:BNTX
NasdaqGS:BNTXBiotechs

Assessing BioNTech (NasdaqGS:BNTX) Valuation After Analyst Moves And COVID Vaccine Trial Setback

Analyst reactions and trial setback keep focus on BioNTech (NasdaqGS:BNTX) Recent analyst actions, a CEO transition, softer COVID guidance, and the halt of recruitment in a major US COVID-19 vaccine trial have kept investor attention squarely on BioNTech (NasdaqGS:BNTX). See our latest analysis for BioNTech. Recent price action reflects that tension, with a 6.42% 7 day share price return and a 1.97% move higher in the latest session coming after a 10.56% 1 month share price decline and a...
NYSE:FRO
NYSE:FROOil and Gas

Frontline (NYSE:FRO) Valuation Check As Tanker Disruptions Tighten Supply And Lift Spot Charter Rates

Why Frontline’s board changes matter against a tighter tanker market Recent disruptions in the Strait of Hormuz are forcing crude tankers onto longer routes, tightening vessel supply and lifting spot charter rates, which puts Frontline (NYSE:FRO) in focus for investors tracking tanker earnings sensitivity. See our latest analysis for Frontline. Frontline’s latest share price of US$36.60 sits on top of strong recent momentum, with a 90 day share price return of 77.84% and a 1 year total...
TSE:7936
TSE:7936Luxury

Assessing ASICS (TSE:7936) Valuation After Recent Share Price Pullback And Strong Multi Year Returns

ASICS shares after recent performance ASICS (TSE:7936) has been on many investors’ radar after a mixed share price pattern, with a roughly 7% decline over the past month alongside a gain of about 15% in the past 3 months. See our latest analysis for ASICS. Recent share price softness, including a 7.5% 1 month share price return decline to ¥4,306, contrasts with strong longer term momentum, with a 1 year total shareholder return of 56.5% and a very large 5 year total shareholder return. If...
NYSE:CPK
NYSE:CPKGas Utilities

Chesapeake Utilities (CPK) Valuation Check After New Leadership Moves And Growth Signals

Why Chesapeake Utilities stock is back in focus Chesapeake Utilities (CPK) is back on investors' radars after a fresh round of leadership moves, including naming Michael Galtman as chief transformation officer and Melissa Barnes as vice president and chief accounting officer. These appointments tie directly to the company's enterprise resource planning project and finance function, giving investors new information about how Chesapeake Utilities is organizing leadership around its long term...
SEHK:576
SEHK:576Infrastructure

A Look At Zhejiang Expressway (SEHK:576) Valuation After 2025 Results And Dividend Increase

Zhejiang Expressway (SEHK:576) has released new figures for its 2025 full year earnings, together with a proposed dividend increase. This combination gives income focused investors new information to assess. See our latest analysis for Zhejiang Expressway. At a share price of HK$7.45, Zhejiang Expressway has seen a 1 month share price return of 7.97%, while its 1 year total shareholder return of 21.27% and 3 year total shareholder return of 53.43% point to momentum that has built over time...
NYSE:BOOT
NYSE:BOOTSpecialty Retail

Why Boot Barn (BOOT) Is Down 9.4% After Raising Guidance And Expanding Store Growth Plans

Boot Barn Holdings recently reported past quarterly results that exceeded revenue and earnings estimates, fueled by higher transaction volumes and continued new store openings, and raised its guidance for the coming fiscal year while outlining additional expansion plans. Despite these stronger-than-expected results, investor reactions have been mixed as some shareholders focus on the company’s cautious near-term outlook and the risk of slower growth ahead. Now we’ll examine how the...
NYSE:TX
NYSE:TXMetals and Mining

How Ternium’s 2025 Low‑Carbon Steel 20‑F Filing Could Impact Ternium (TX) Investors

On March 31, 2026, Ternium S.A. filed its 2025 Form 20-F with the SEC, outlining its operational, financial and sustainability progress, including investments in low-carbon steelmaking technologies and advanced products for the energy transition. The filing gives investors a more detailed view of how Ternium is positioning itself as a supplier of lower-emission steel solutions across the Americas, with an emphasis on sustainable mobility and transparency in reporting. Now, we’ll explore how...
TSE:7974
TSE:7974Entertainment

Assessing Nintendo (TSE:7974) Valuation As Shares Weaken Despite Strong Three Year Returns

Nintendo stock performance snapshot Nintendo (TSE:7974) has been trading without a clear single news catalyst recently. As a result, investors have been focusing on its share price moves, valuation signals and reported financial metrics when assessing the stock. See our latest analysis for Nintendo. At a share price of ¥8,736.0, Nintendo’s recent 7 day share price return of a 5.2% decline and year to date share price return of an 18.0% decline contrast with a 3 year total shareholder return...
NYSE:MHK
NYSE:MHKConsumer Durables

Assessing Mohawk Industries (MHK) Valuation After Recent Share Price Weakness

Understanding Mohawk Industries after recent share performance Mohawk Industries (MHK) has drawn attention after its share price showed a 2.7% decline over the past day, together with negative returns over the month and past 3 months, prompting closer inspection of its fundamentals. See our latest analysis for Mohawk Industries. At a share price of US$96.80, Mohawk Industries has seen its 1 month share price return of a 10.95% decline extend a weaker pattern that leaves the year to date share...
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

How Investors May Respond To ACM Research (ACMR) Planetary Family Multi-Product Rebranding

On 2 April 2026, ACM Research, Inc. reorganized its expanding semiconductor equipment portfolio into the ACM Planetary Family, grouping tools into eight process-based series spanning cleaning, advanced packaging, electroplating, furnace, track, PECVD, panel-level packaging and stress-free polishing applications. This shift from a single-product focus to a clearer, process-aligned multi-product lineup highlights ACM's intent to strengthen technology differentiation and better match complex...
NasdaqGS:IMVT
NasdaqGS:IMVTBiotechs

Should Batoclimab’s Phase 3 Miss in Thyroid Eye Disease Require Action From Immunovant (IMVT) Investors?

In early April 2026, Immunovant reported topline data showing that its two Phase 3 GO studies of batoclimab in adults with active, moderate-to-severe thyroid eye disease did not meet the primary endpoint of a 2mm or greater proptosis responder rate at Week 24, although safety remained consistent with prior findings and no new signals emerged. The company highlighted that proptosis improvements were greater during the initial high-dose period, reinforcing the role of deeper IgG suppression,...
NasdaqCM:SBET
NasdaqCM:SBETHospitality

Assessing Sharplink (SBET) Valuation With A 43.5x P/S And Mixed Treasury Growth Signals

Sharplink: Business mix and recent share performance Sharplink (SBET) has drawn fresh attention after recent share price volatility, with the stock showing a 4.2% decline over the past day, a 2.5% gain over the past week, and weaker returns over the past month and past 3 months. Over the past year, Sharplink’s total return is close to 99%, while its 3 year total return reflects a loss of about 87%. Year to date, the stock is down about 36%, giving the company a market value of roughly...
NYSE:A
NYSE:ALife Sciences

Agilent Technologies (A) Valuation Check After New Cell Imaging And Cancer Diagnostic Milestones

Agilent Technologies (A) has just added two fresh product milestones: the BioTek Cytation 9 cell imaging multimode reader and an FDA cleared PD-L1 IHC 22C3 companion diagnostic, giving investors new context for thinking about the stock. See our latest analysis for Agilent Technologies. These product launches and the recent dividend announcement come against a mixed backdrop, with a 7 day share price return of 4.75%, a 90 day share price return of 16.29%, and a 3 year total shareholder return...
TSE:4091
TSE:4091Chemicals

Will Nippon Sanso’s “Next Innovation 2030” Shift Its Profit Mix and Narrative (TSE:4091)?

Nippon Sanso Holdings has launched its “Next Innovation 2030” plan, aiming to lift industrial gas profitability, expand its electronics business, and build new growth engines beyond its foundational phase. This shift from consolidation to proactive expansion marks a meaningful repositioning of Nippon Sanso’s business mix toward higher-potential segments and innovation-led income streams. We’ll now examine how the Next Innovation 2030 focus on boosting industrial gas profitability could...
NasdaqGS:HAS
NasdaqGS:HASLeisure

How Investors May Respond To Hasbro (HAS) Cyberattack Exposing Weeks-Long Supply Chain Disruptions

In late March 2026, Hasbro disclosed a cyberattack that forced parts of its manufacturing and shipping systems offline, prompting business continuity measures and warning of potential delivery delays lasting several weeks. The incident tests the resilience of Hasbro’s increasingly streamlined supply chain and its efforts to improve efficiency and reliability across omni-channel distribution. We’ll now examine how this cyberattack, and the risk of weeks-long product delays, may affect...
NasdaqGS:PTON
NasdaqGS:PTONLeisure

How Investors Are Reacting To Peloton (PTON) Expanding Into Commercial Gyms And Refreshing Its Leadership

In recent days Peloton Interactive reported margin expansion and adjusted EBITDA growth while unveiling plans to roll out its Peloton Commercial Series bikes and treadmills for gyms from late 2026, alongside leadership changes including the appointment of Sarah Robb O’Hagan as Chief Content and Member Development Officer and the departure of CFO Liz Coddington. These developments highlight Peloton’s push to extend beyond at-home fitness into commercial facilities and connected wellness,...
NYSE:ADT
NYSE:ADTConsumer Services

A Look At ADT’s Valuation After Ariel Focus Fund Addition And New Partnership Momentum

Fund addition sharpens focus on ADT The addition of ADT (ADT) to Ariel Focus Fund, together with its partnerships with Google and State Farm, has put fresh attention on the security provider’s recurring revenue model and perceived competitive position. See our latest analysis for ADT. At a share price of $6.62, ADT has a 90 day share price return of 17.35% decline and a year to date share price return matching that move, while the 1 year total shareholder return of 14.66% decline contrasts...
OB:ENTRA
OB:ENTRAReal Estate

A Look At Entra (OB:ENTRA) Valuation As Key Board Members Step Down

Board changes put governance in focus Entra (OB:ENTRA) has flagged a major board reshuffle at its April 21, 2026 AGM, with chair Ottar Ertzeid and board members Hege Toft Karlsen and Camilla AC Tepfers all declining re-election. See our latest analysis for Entra. The leadership news comes as Entra’s share price, at NOK106.4, shows short term momentum with a 7 day share price return of 4.11%. However, the 1 year total shareholder return has declined by 6.44% and the 5 year total shareholder...
TSE:1721
TSE:1721Construction

A Look At COMSYS Holdings (TSE:1721) Valuation After An 11.27% Share Cancellation

What COMSYS Holdings’ Large Share Cancellation Means For Investors COMSYS Holdings (TSE:1721) has just cancelled 15,000,000 shares, cutting its previously issued share count by 11.27%. This sizable reduction focuses attention on capital efficiency and the potential impact on per share metrics. See our latest analysis for COMSYS Holdings. The latest share cancellation comes after a period where the 1-year total shareholder return of 70.35% far exceeded the 10.59% year-to-date share price...
NYSE:COLD
NYSE:COLDIndustrial REITs

Does Activist Pressure To Oust Americold’s Chair And Weigh A Sale Transform The Bull Case For COLD?

On March 30, 2026, activist investor Sieve Capital LLC publicly urged Americold Realty Trust’s board to remove Chairman Mark Patterson, oppose his re-election at the 2026 Annual Meeting, and launch a full review of strategic alternatives, including a potential sale, following reports of inbound interest. Sieve Capital has also flagged what it describes as problematic governance and a history of poor strategic decisions under Patterson at multiple companies, arguing that shareholders deserve...
NasdaqGS:MAT
NasdaqGS:MATLeisure

The Bull Case For Mattel (MAT) Could Change Following Masters of the Universe Global Product Push

In March 2026, Mattel announced a global, cross-category product line inspired by the upcoming live-action “Masters of the Universe” film, spanning toys, gaming, collectibles, apparel and more, with products starting to reach shelves worldwide from April 25, 2026. What stands out is the breadth of licensing and retail partnerships, over 70 partners across multiple categories, positioning Masters of the Universe as a broad entertainment and consumer-products platform rather than just a toy...
NasdaqGS:SRPT
NasdaqGS:SRPTBiotechs

Sarepta Therapeutics (SRPT) Is Up 16.3% After Early siRNA Muscle Data Validates Avß6 Platform

In late March 2026, Sarepta Therapeutics reported first-in-human Phase 1/2 data for its SRP-1001 and SRP-1003 siRNA programs in facioscapulohumeral muscular dystrophy type 1 and myotonic dystrophy type 1, showing dose-dependent muscle exposure, early biomarker effects and generally favorable tolerability using its avß6 integrin-targeted delivery platform. The early proof-of-concept knockdown of target protein or mRNA not only supports these rare disease programs, but also strengthens the...